Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Phase 2

Completed

• Conditions: Blood Glucose, Postprandial

• Registration Number: NCT00801814
• Lead Sponsor: Glycemic Index Laboratories, Inc

Brief Summary

To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04
• Primary Completion: 2006-05
• Study Completion: 2006-08
• Status Verified: 2008-12
• Study First Submitted: 2008-12-03
• Study First Submitted QC: 2008-12-03
• Last Update Submitted: 2008-12-03
• Study First Posted: 2008-12-04
• Last Update Posted: 2008-12-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• healthy individuals
• 18-75 years old
• BMI less than 35 kg/m2

Exclusion Criteria

• Medications influencing gastrointestinal function
• Pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
postprandial glycemia	Acute study measuring postprandial glucose levels over 2 hours

Secondary Outcome Measures

Name	Time	Method
The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber.	Data analysis

Trial Locations

Locations (1)

Glycemic Index Laboratories, Inc.; 🇨🇦 Toronto, Ontario, Canada